These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9584847)

  • 1. Prostatic acid phosphatase: structural aspects of inhibition by L-(+)-tartrate ions.
    Lovelace L; Lewiński K; Jakob CG; Kuciel R; Ostrowski W; Lebioda L
    Acta Biochim Pol; 1997; 44(4):673-8. PubMed ID: 9584847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural origins of L(+)-tartrate inhibition of human prostatic acid phosphatase.
    LaCount MW; Handy G; Lebioda L
    J Biol Chem; 1998 Nov; 273(46):30406-9. PubMed ID: 9804805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L(+)-tartrate inhibition of acid phosphatase isozymes from rat prostate.
    Paul SE; Richardson KE
    Invest Urol; 1969 Nov; 7(3):232-9. PubMed ID: 5380894
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochemistry and biochemistry of acid phosphatases. III. Inhibition experiments of lysosomal and secretory acid phosphatases of the rat ventral prostate.
    Seitz J; Aumuller G
    Basic Appl Histochem; 1981; 25(2):95-104. PubMed ID: 6455992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structure of rat acid phosphatase in complex with L(+)-tartrate.
    Lindqvist Y; Schneider G; Vihko P
    J Biol Chem; 1993 Oct; 268(28):20744-6. PubMed ID: 8407898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray studies of crystalline complexes involving amino acids and peptides. XLIV. Invariant features of supramolecular association and chiral effects in the complexes of arginine and lysine with tartaric acid.
    Selvaraj M; Thamotharan S; Roy S; Vijayan M
    Acta Crystallogr B; 2007 Jun; 63(Pt 3):459-68. PubMed ID: 17507759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of tartrate-sensitive and tartrate-resistant acid phosphatase indicated from the study of their biosynthetic mechanism.
    Lam WK; Siemen M; Lee JC; Yam LT; Li CY; Wold LE
    Clin Physiol Biochem; 1987; 5(6):305-14. PubMed ID: 2451579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tartrate-inhibitable lysosomal acid phosphatase. Purification, characterization, biosynthesis and intracellular transport.
    Gieselmann V; Lemansky P; Hasilik A; von Figura K; Waheed A; van Etten RL
    Acta Biochim Pol; 1986; 33(2):119-26. PubMed ID: 3766012
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystal structure of a mammalian purple acid phosphatase.
    Uppenberg J; Lindqvist F; Svensson C; Ek-Rylander B; Andersson G
    J Mol Biol; 1999 Jul; 290(1):201-11. PubMed ID: 10388567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theoretical investigations of prostatic acid phosphatase.
    Sharma S; Pirilä P; Kaija H; Porvari K; Vihko P; Juffer AH
    Proteins; 2005 Feb; 58(2):295-308. PubMed ID: 15578709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride inhibition of bovine spleen purple acid phosphatase: characterization of a ternary enzyme-phosphate-fluoride complex as a model for the active enzyme-substrate-hydroxide complex.
    Pinkse MW; Merkx M; Averill BA
    Biochemistry; 1999 Aug; 38(31):9926-36. PubMed ID: 10433699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
    Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
    J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
    Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
    J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the subunit of prostatic phosphatase active? Reversible denaturation of prostatic acid phosphatase.
    Kuciel R; Bakalova A; Mazurkiewicz A; Bilska A; Ostrowski W
    Biochem Int; 1990 Oct; 22(2):329-34. PubMed ID: 2090098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dog and human gastric lipases by enantiomeric phosphonate inhibitors: a structure-activity study.
    Miled N; Roussel A; Bussetta C; Berti-Dupuis L; Rivière M; Buono G; Verger R; Cambillau C; Canaan S
    Biochemistry; 2003 Oct; 42(40):11587-93. PubMed ID: 14529268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionation and purification of prostatic acid phosphatase.
    Pais VM; Mangold AW; Mahoney SA
    Invest Urol; 1974 Jul; 12(1):13-6. PubMed ID: 4135033
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of iodination on the activity and structure of acid phosphomonoesterase from human prostate.
    Bobrzecka K; Ostrowski W; Rybarska J
    Acta Biochim Pol; 1968; 15(4):369-79. PubMed ID: 4181223
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tartrate-sensitive and tartrate-resistant acid phosphatases in Amoeba proteus].
    Sopina VA; Beliaeva TN
    Tsitologiia; 2000; 42(6):602-12. PubMed ID: 10953868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.